Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Solubility: DMSO: 50 mg/mL(199
Formula: C14H12BrN5
Combination with radiation
AG-1517 inhibits EGF-stimulated receptor autophosphorylation in A431 human epidermoid carcinoma cells
In the same dose range
Saxagliptin in HCl Solubility: DMSO: 50 mg/mL(199Saxagliptin, also known as BMS 477118, is a new oral hypoglycemic (anti diabetic drug) of the new dipeptidyl peptidase 4 (DPP 4) inhibitor class of drugs. Saxagliptin was approved in 2008 for the treatment of type 2 diabetes. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones, thereby increasing their bloodstream concentrations and reducing fasting and postprandial glucose concentrations in a glucose